| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ |
|---|---|---|---|
| Revenue | $1.2B | $4.3B | $4.2B |
| Cost of Revenue | — | — | — |
| Gross Profit | — | — | — |
| R&D Expense | $0.0B | $0.1B | $0.1B |
| SG&A Expense | $0.1B | $0.5B | $0.6B |
| Operating Income | $0.2B | $0.4B | $0.3B |
| Net Income | $0.1B | $0.1B | $-0.1B |
| EPS (Basic) | $1.13 | $1.26 | $-1.90 |
| EPS (Diluted) | $1.09 | $1.23 | $-1.90 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ |
|---|---|---|---|
| Total Assets | $5.7B | $5.6B | $5.7B |
| Current Assets | $1.8B | $1.8B | $1.9B |
| Cash & Equivalents | $0.5B | $0.4B | $0.3B |
| Total Liabilities | $5.3B | $5.3B | $5.5B |
| Current Liabilities | $1.9B | $1.7B | $1.7B |
| Stockholders' Equity | $0.4B | $0.3B | $0.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ |
|---|---|---|---|
| Operating Cash Flow | $0.4B | $0.3B | $0.4B |
| Investing Cash Flow | $-0.1B | $-0.1B | $-0.3B |
| Capital Expenditures | $0.1B | $0.1B | $0.1B |
| Financing Cash Flow | $-0.3B | $-0.1B | $0.0B |